{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T17:55:48Z","timestamp":1770746148136,"version":"3.49.0"},"reference-count":32,"publisher":"BMJ","issue":"4","license":[{"start":{"date-parts":[[2020,4,8]],"date-time":"2020-04-08T00:00:00Z","timestamp":1586304000000},"content-version":"unspecified","delay-in-days":7,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2020,3,17]]},"published-print":{"date-parts":[[2020,4]]},"abstract":"<jats:p>We present the case of a patient whose skin findings and human leucocyte antigen (HLA) typing were key findings for the diagnosis of his neuro-Sweet disease. A 55-year-old Japanese man with skin rashes and high fever suddenly developed consciousness disturbance, and brain MRI showed encephalitis and leptomeningitis. Neuro-Beh\u00e7et disease or microbial infection was initially suspected, but he was eventually diagnosed with neuro-Sweet disease based on his skin rashes and pathology and the presence of HLA-B54 and Cw1. He responded to glucocorticoid and recovered without neurological sequelae. The involvement of cytokines has been implicated in the pathogenesis of Sweet disease, but the number of cytokines assayed in each case report is limited. In our patient\u2019s case, the result of a 27-cytokine assay showed increases in a wide range of bioactive substances including inflammatory cytokines, growth factors and chemoattractants in the active phase, indicating the involvement of multiple cytokines in the pathogenesis of Sweet disease.<\/jats:p>","DOI":"10.1136\/bcr-2019-233457","type":"journal-article","created":{"date-parts":[[2020,4,9]],"date-time":"2020-04-09T05:59:44Z","timestamp":1586411984000},"page":"e233457","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Increase of a wide range of bioactive substances in an active phase of neuro-Sweet disease"],"prefix":"10.1136","volume":"13","author":[{"given":"Hiroi","family":"Kusaka","sequence":"first","affiliation":[{"name":"Division of Rheumatology and Clinical Immunology, Jichi Medical University, Simotsuke, Tochigi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2877-189X","authenticated-orcid":false,"given":"Katsuya","family":"Nagatani","sequence":"additional","affiliation":[{"name":"Division of Rheumatology and Clinical Immunology, Jichi Medical University, Simotsuke, Tochigi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeo","family":"Sato","sequence":"additional","affiliation":[{"name":"Division of Rheumatology and Clinical Immunology, Jichi Medical University, Simotsuke, Tochigi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiji","family":"Minota","sequence":"additional","affiliation":[{"name":"Division of Rheumatology and Clinical Immunology, Jichi Medical University, Simotsuke, Tochigi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2020,4,8]]},"reference":[{"key":"2025082708445432000_13.4.e233457.1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1964.tb14541.x"},{"key":"2025082708445432000_13.4.e233457.2","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-2-34"},{"key":"2025082708445432000_13.4.e233457.3","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1365-2141.1993.tb03083.x","article-title":"Sweet's syndrome associated with myelodysplasia: possible role of cytokines in the pathogenesis of the disease","volume":"84","author":"Reuss-Borst","year":"1993","journal-title":"Br J Haematol"},{"key":"2025082708445432000_13.4.e233457.4","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1212\/01.WNL.0000161848.34159.B5","article-title":"Neuro-Sweet disease: clinical manifestations and criteria for diagnosis","volume":"64","author":"Hisanaga","year":"2005","journal-title":"Neurology"},{"key":"2025082708445432000_13.4.e233457.5","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1983.04050120079018"},{"key":"2025082708445432000_13.4.e233457.6","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.56.8.1010"},{"key":"2025082708445432000_13.4.e233457.7","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2169\/internalmedicine.46.0175","article-title":"Neuro-neutrophilic disease: neuro-Beh\u00e7et disease and neuro-Sweet disease","volume":"46","author":"Hisanaga","year":"2007","journal-title":"Intern Med"},{"key":"2025082708445432000_13.4.e233457.8","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1988.01670070057019"},{"key":"2025082708445432000_13.4.e233457.9","first-page":"267","article-title":"Sweet's syndrome: unique local response to streptococcal antigen","volume":"17","author":"Petrozzi","year":"1976","journal-title":"Cutis"},{"key":"2025082708445432000_13.4.e233457.10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1412998"},{"key":"2025082708445432000_13.4.e233457.11","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.16.2933"},{"key":"2025082708445432000_13.4.e233457.12","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1365-4632.2012.05840.x","article-title":"Interferon beta-1b-induced sweet's syndrome in a patient with multiple sclerosis","volume":"54","author":"Kim","year":"2015","journal-title":"Int J Dermatol"},{"key":"2025082708445432000_13.4.e233457.13","article-title":"Sweet syndrome associated with interferon","volume":"21","author":"Rodriguez-Lojo","year":"2014","journal-title":"Dermatol Online J"},{"key":"2025082708445432000_13.4.e233457.14","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.20112"},{"key":"2025082708445432000_13.4.e233457.15","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.140.5.570"},{"key":"2025082708445432000_13.4.e233457.16","doi-asserted-by":"crossref","DOI":"10.1186\/s13256-017-1317-0","article-title":"Serum cytokine profile in pediatric sweet's syndrome: a case report","volume":"11","author":"Takano","year":"2017","journal-title":"J Med Case Rep"},{"key":"2025082708445432000_13.4.e233457.17","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/cei.12394","article-title":"Expression of cytokines, chemokines and other effector molecules in two prototypic autoinflammatory skin diseases, pyoderma gangrenosum and sweet's syndrome","volume":"178","author":"Marzano","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"2025082708445432000_13.4.e233457.18","doi-asserted-by":"crossref","first-page":"613","DOI":"10.3109\/10428199809057622","article-title":"Sweet's syndrome during treatment with all-trans retinoic acid in a patient with acute promyelocytic leukemia","volume":"31","author":"Arun","year":"1998","journal-title":"Leuk Lymphoma"},{"key":"2025082708445432000_13.4.e233457.19","doi-asserted-by":"publisher","DOI":"10.1177\/039463201102400218"},{"key":"2025082708445432000_13.4.e233457.20","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(98)70266-X"},{"key":"2025082708445432000_13.4.e233457.21","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2169\/internalmedicine.47.0370","article-title":"Longitudinal analysis of cytokines and chemokines in the cerebrospinal fluid of a patient with neuro-Sweet disease presenting with recurrent encephalomeningitis","volume":"47","author":"Kimura","year":"2008","journal-title":"Intern Med"},{"key":"2025082708445432000_13.4.e233457.22","doi-asserted-by":"crossref","first-page":"1348.2","DOI":"10.3899\/jrheum.080698","article-title":"Etanercept treatment in sweet's syndrome with inflammatory arthritis","volume":"36","author":"Ambrose","year":"2009","journal-title":"J Rheumatol"},{"key":"2025082708445432000_13.4.e233457.23","doi-asserted-by":"publisher","DOI":"10.1159\/000326112"},{"key":"2025082708445432000_13.4.e233457.24","first-page":"376","article-title":"Regression of sweet's syndrome associated with Crohn's disease after anti-tumour necrosis factor therapy","volume":"68","author":"Rahier","year":"2005","journal-title":"Acta Gastroenterol Belg"},{"key":"2025082708445432000_13.4.e233457.25","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s13760-016-0695-1","article-title":"Neuro sweet syndrome: a systematic review. A rare complication of sweet syndrome","volume":"117","author":"Drago","year":"2017","journal-title":"Acta Neurol Belg"},{"key":"2025082708445432000_13.4.e233457.26","doi-asserted-by":"crossref","DOI":"10.4081\/ni.2012.e5","article-title":"Two cases of possible neuro-Sweet disease with meningoencephalitis as the initial manifestation","volume":"4","author":"Makimoto","year":"2012","journal-title":"Neurol Int"},{"key":"2025082708445432000_13.4.e233457.27","doi-asserted-by":"crossref","first-page":"e513","DOI":"10.1111\/ijd.13287","article-title":"Neuro-Sweet's disease.","volume":"55","author":"Kitamura","year":"2016","journal-title":"Int J Dermatol"},{"key":"2025082708445432000_13.4.e233457.28","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1159\/000098473","article-title":"Sweet's syndrome associated with acute-onset encephalitis","volume":"57","author":"Song","year":"2007","journal-title":"Eur Neurol"},{"key":"2025082708445432000_13.4.e233457.29","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jns.2008.08.006","article-title":"Reversible extensive leukoencephalopathy in sweet disease: a case report","volume":"275","author":"Fukushima","year":"2008","journal-title":"J Neurol Sci"},{"key":"2025082708445432000_13.4.e233457.30","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2006.105650"},{"key":"2025082708445432000_13.4.e233457.31","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A1937"},{"key":"2025082708445432000_13.4.e233457.32","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3109\/s10165-011-0533-5","article-title":"Clinical characteristics of neuro-Behcet's disease in Japan: a multicenter retrospective analysis","volume":"22","author":"Hirohata","year":"2012","journal-title":"Mod Rheumatol"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2019-233457","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T15:45:06Z","timestamp":1756309506000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2019-233457"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":32,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,4,8]]},"published-print":{"date-parts":[[2020,4]]}},"alternative-id":["10.1136\/bcr-2019-233457"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2019-233457","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4]]}}}